SenesTech, Inc.
SenesTech, Inc. is listed today as SenesTech, Inc.: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 4 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2023 | $2 M | Private placement after listing | Under $2 million | equity, options | SEC | |
| Jan 2021 | $10 M | Private placement after listing | $10 to $50 million | equity, options | SEC | |
| Oct 2020 | $3 M | Private placement after listing | $2 to $10 million | equity, options | SEC | |
| Jan 2020 | $2 M | Private placement after listing | Under $2 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
SenesTech, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2023).
SEC Form D · Apr 2023
The industry group it chose in its notices: Biotechnology.
SEC Form D · Apr 2023
That is all the official record says: SenesTech, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of SenesTech, Inc. are on record.
Investors#
No investor of SenesTech, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Largest shareholders today
Institutions holding SenesTech, Inc. shares, as of Sep 30, 2026.
- Sabby Management, LLC$0 M5.77%
- Citadel Advisors LLC$0 M1.29%
- Geode Capital Management, LLC$0 M0.89%
- Gsa Capital Partners LLP$0 M0.86%
- Vanguard Capital Management LLC$0 M0.64%
- Renaissance Technologies LLC$0 M0.64%
- Vanguard Fiduciary Trust Co$0 M0.49%
- Essex Investment Management Co LLC$0 M0.48%
- XTX Topco Ltd$0 M0.40%
- Diversify Advisory Services, LLC$0 M0.35%
- Northern Trust Corp$0 M0.32%
- State Street Corp$0 M0.30%
- Jane Street Group, LLC$0 M0.26%
- Susquehanna International Group, LLP$0 M0.23%
- HRT Financial LP$0 M0.21%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Joel L. Fruendt | Chief Executive Officer | Apr 2023 |
| Nicole L. Williams | Chief Revenue Officer | Apr 2023 |
| Thomas C. Chesterman | Executive Vice President, Chief Financial Officer, Treasurer and Secretary | Apr 2023 |
| Kenneth Siegel | Chief Executive Officer and Director | Feb 2021 |
| Kim C Wolin | Executive Vice President, Operations and Secretary | Feb 2021 |
| Steven C Krause, Ph.D. | Executive Vice President, Sales and Marketing | Feb 2021 |
| Thomas C Chesterman | Chief Financial Officer | Feb 2021 |
| Delphine Francois Chiavarini | Director | Apr 2023 |
| Jake K. Leach | Director | Apr 2023 |
| Jamie K. Bechtel, JD, Ph.D. | Director | Apr 2023 |
| Joel L. Fruendt | Chief Executive Officer | Apr 2023 |
| Marc C. Dumont | Director | Apr 2023 |
| Matthew K. Szot | Director | Apr 2023 |
| Nicole L. Williams | Chief Revenue Officer | Apr 2023 |
| Phil L. Grandinetti, III | Director | Apr 2023 |
| Delphine C Chiavarini | Director | Feb 2021 |
| Jake C Leach | Director | Feb 2021 |
| Jamie C Bechtel, JD, Ph.D. | Director | Feb 2021 |
| K.C. C Kavanagh | Director | Feb 2021 |
| Kenneth Siegel | Chief Executive Officer and Director | Feb 2021 |
| Marc C Dumont | Director | Feb 2021 |
| Matthew C Szot | Director | Feb 2021 |
| Phil C Grandinetti, III | Director | Feb 2021 |
| Julie Francois Williams, MD | Director | Nov 2020 |
| Marc Francois Dumont | Director | Nov 2020 |
| Matthew Francois Szot | Director | Nov 2020 |
Went public since 2016. Its SEC number is that of a company listed on a stock exchange.